Literature DB >> 26427566

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.

Jeffrey C Weinreb1, Jelle O Barentsz2, Peter L Choyke3, Francois Cornud4, Masoom A Haider5, Katarzyna J Macura6, Daniel Margolis7, Mitchell D Schnall8, Faina Shtern9, Clare M Tempany10, Harriet C Thoeny11, Sadna Verma12.   

Abstract

The Prostate Imaging - Reporting and Data System Version 2 (PI-RADS™ v2) is the product of an international collaboration of the American College of Radiology (ACR), European Society of Uroradiology (ESUR), and AdMetech Foundation. It is designed to promote global standardization and diminish variation in the acquisition, interpretation, and reporting of prostate multiparametric magnetic resonance imaging (mpMRI) examination, and it is based on the best available evidence and expert consensus opinion. It establishes minimum acceptable technical parameters for prostate mpMRI, simplifies and standardizes terminology and content of reports, and provides assessment categories that summarize levels of suspicion or risk of clinically significant prostate cancer that can be used to assist selection of patients for biopsies and management. It is intended to be used in routine clinical practice and also to facilitate data collection and outcome monitoring for research.
Copyright © 2015 European Association of Urology. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Prostate; Prostate MRI; Prostate cancer; Prostate mpMRI

Mesh:

Year:  2015        PMID: 26427566      PMCID: PMC6467207          DOI: 10.1016/j.eururo.2015.08.052

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  691 in total

1.  Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.

Authors:  Edward Chang; Tonye A Jones; Shyam Natarajan; Devi Sharma; Demetrios Simopoulos; Daniel J Margolis; Jiaoti Huang; Frederick J Dorey; Leonard S Marks
Journal:  J Urol       Date:  2017-07-18       Impact factor: 7.450

2.  Structured reporting in petrous bone MRI examinations: impact on report completeness and quality.

Authors:  Marco Armbruster; Sebastian Gassenmaier; Mareike Haack; Maximilian Reiter; Dominik Nörenberg; Thomas Henzler; Nora N Sommer; Wieland H Sommer; Franziska Braun
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-07-23       Impact factor: 2.924

3.  Accelerated Segmented Diffusion-Weighted Prostate Imaging for Higher Resolution, Higher Geometric Fidelity, and Multi-b Perfusion Estimation.

Authors:  Pelin Aksit Ciris; Jr-Yuan George Chiou; Daniel I Glazer; Tzu-Cheng Chao; Clare M Tempany-Afdhal; Bruno Madore; Stephan E Maier
Journal:  Invest Radiol       Date:  2019-04       Impact factor: 6.016

4.  Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.

Authors:  Shivani Pahwa; Nicholas K Schiltz; Lee E Ponsky; Ziang Lu; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-05-17       Impact factor: 11.105

5.  Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.

Authors:  Abhinav Sidana; Matthew J Watson; Arvin K George; Ardeshir R Rastinehad; Srinivas Vourganti; Soroush Rais-Bahrami; Akhil Muthigi; Mahir Maruf; Jennifer B Gordetsky; Jeffrey W Nix; Maria J Merino; Baris Turkbey; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Urol Oncol       Date:  2018-05-10       Impact factor: 3.498

6.  Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Authors:  Julie Y An; Stephanie A Harmon; Sherif Mehralivand; Marcin Czarniecki; Clayton P Smith; Julie A Peretti; Bradford J Wood; Peter A Pinto; Peter L Choyke; Joanna H Shih; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2018-12

7.  Learning Non-rigid Deformations for Robust, Constrained Point-based Registration in Image-Guided MR-TRUS Prostate Intervention.

Authors:  John A Onofrey; Lawrence H Staib; Saradwata Sarkar; Rajesh Venkataraman; Cayce B Nawaf; Preston C Sprenkle; Xenophon Papademetris
Journal:  Med Image Anal       Date:  2017-04-12       Impact factor: 8.545

Review 8.  Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

Authors:  Steven P Rowe; Alexander Drzezga; Bernd Neumaier; Markus Dietlein; Michael A Gorin; Michael R Zalutsky; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-10       Impact factor: 10.057

9.  Prostate cancer: Birth of a standard: MET-RADS-P for metastatic prostate cancer.

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Nat Rev Urol       Date:  2016-08-31       Impact factor: 14.432

10.  Detection of prostate cancer local recurrence following radical prostatectomy: assessment using a continuously acquired radial golden-angle compressed sensing acquisition.

Authors:  Andrew B Rosenkrantz; Anunita Khasgiwala; Ankur M Doshi; Justin M Ream; Samir S Taneja; Herbert Lepor
Journal:  Abdom Radiol (NY)       Date:  2017-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.